Omeros Corp logo

Omeros Corp

FRA:3O8 (USA)   Ordinary Shares
€ 3.15 (+0.64%) Mar 28
Market Cap:
€ 200.02M ($ 215.52M)
Enterprise V:
€ 228.28M ($ 245.98M)
Volume:
-
Avg Vol (2M):
100.00
Also Trade In:

Business Description

Omeros Corp logo
Omeros Corp
NAICS : 325412 SIC : 2834
ISIN : US6821431029

Share Class Description:

FRA:3O8: Ordinary Shares
Description
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Financials (Next Earnings Date:2024-05-09 Est.)

FRA:3O8's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Omeros Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) 0.324
Beta 2.42
Volatility % 131.42
14-Day RSI 38.78
14-Day ATR (€) 0.175304
20-Day SMA (€) 3.5528
12-1 Month Momentum % 8.56
52-Week Range (€) 0.977 - 7.095
Shares Outstanding (Mil) 62.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Omeros Corp Filings

Filing Date Document Date Form
No Filing Data

Omeros Corp Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Omeros Corp Frequently Asked Questions

What is Omeros Corp(FRA:3O8)'s stock price today?
The current price of FRA:3O8 is €3.15. The 52 week high of FRA:3O8 is €7.10 and 52 week low is €0.98.
When is next earnings date of Omeros Corp(FRA:3O8)?
The next earnings date of Omeros Corp(FRA:3O8) is 2024-05-09 Est..
Does Omeros Corp(FRA:3O8) pay dividends? If so, how much?
Omeros Corp(FRA:3O8) does not pay dividend.

Press Release

Subject Date
No Press Release